Actinomycin D for fibrosis management in ophthalmic implant surgery

Actinomycin D for fibrosis management in ophthalmic implant surgery

Implants that feature a drug delivery system loaded with antifibrotic active drugs provide a promising approach to address postoperative complications caused by fibrosis. This study is intended to clarify whether Actinomycin D has an impact specifically on components of the extracellular matrix (ECM...

Full description

Bibliographic Details
Main Authors: Brietzke Andreas, Eickner Thomas, Grabow Niels, Reske Thomas, Matschegewski Claudia, Guthoff Rudolf, Stahnke Thomas
Format: Article
Language:English
Published: De Gruyter 2019-09-01
Series:Current Directions in Biomedical Engineering
Subjects:
fibrosis
ophthalmic implant
drug delivery
actinomycin d
Online Access:https://doi.org/10.1515/cdbme-2019-0121

Internet

https://doi.org/10.1515/cdbme-2019-0121

Similar Items